Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries | Zendy

Melvin Joy | Zendy; B. Malavika | Zendy; Edwin Sam Asirvatham | Zendy; Thambu David Sudarsanam | Zendy; Lakshmanan Jeyaseelan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries

Author(s) -

Melvin Joy,

B. Malavika,

Edwin Sam Asirvatham,

Thambu David Sudarsanam,

Lakshmanan Jeyaseelan

Publication year - 2020

Publication title -

clinical epidemiology and global health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.361

H-Index - 13

eISSN - 2452-0918

pISSN - 2213-3984

DOI - 10.1016/j.cegh.2020.08.015

Subject(s) - medicine , vaccination , incidence (geometry) , demography , population , covid-19 , bcg vaccine , tuberculosis , environmental health , immunology , physics , disease , pathology , sociology , infectious disease (medical specialty) , optics

Global research is running towards to find a vaccine to stop the threat of the COVID-19. The Bacillus Calmette-Guérin (BCG) vaccine that prevents severe forms of tuberculosis is getting more attention in this scenario. The objective of our study was to determine the association between BCG vaccine coverage and incidence of COVID-19 at a national-level across the Globe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research